American Journal of Cardiovascular Drugs
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.2 | Q2 | 64.1% | 0.952 | Q1 | 82.6% |
| 2024 | 3.0 | Q2 | 67.4% | 0.876 | Q2 | 80.6% |
| 2023 | 2.8 | Q2 | 56.4% | 0.790 | Q2 | 79.4% |
| 2022 | 3.0 | Q3 | 53.3% | 0.841 | Q2 | 81.9% |
| 2021 | 3.3 | Q3 | 55.1% | 1.010 | Q1 | 86.7% |
| 2020 | — | — | 1.063 | Q1 | 86.6% | |
| 2019 | — | — | 0.854 | Q2 | 82.0% | |
| 2018 | — | — | 0.903 | Q1 | 81.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1179-187X
ISSN
1175-3277
country
CHcoverage
2001-2026